APA (7th ed.) Citation

Ghada Elshimy MD, Anand Gandhi MD, Rong Guo MD, & Ricardo Correa MD, E. (2020). Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. SAGE Publishing.

Chicago Style (17th ed.) Citation

Ghada Elshimy MD, Anand Gandhi MD, Rong Guo MD, and EsD Ricardo Correa MD. Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. SAGE Publishing, 2020.

MLA (9th ed.) Citation

Ghada Elshimy MD, et al. Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. SAGE Publishing, 2020.